1 vegetable capsule per serving | 30 servings | 20 billion CFU probiotic blend | FOS 360 mg | Cranberry fruit extract 100 mg, at least 25% PACs | Zinc 15 mg | Vitamin D3 25 mcg (1,000 IU) | Custom order
A women’s probiotic page should show why the formula belongs in that segment instead of relying on a pink label or the presence of cranberry. This one-capsule concept combines a 20 billion CFU probiotic blend with FOS, standardized cranberry fruit extract, zinc and vitamin D3. The final positioning depends on the exact strain set, the cranberry specification and a viable-count plan for the finished package.
| Ingredient | Amount per serving |
| Probiotic blend | 20 billion CFU |
| Fructooligosaccharides (FOS) | 360 mg |
| Cranberry fruit extract | 100 mg / at least 25% proanthocyanidins (PACs) |
| Zinc from zinc-enriched yeast | 15 mg |
| Vitamin D3 as cholecalciferol | 25 mcg (1,000 IU) |
| Serving size | 1 vegetable capsule |
| Pack | 30 capsules / 30 servings |
The label summary does not yet provide the complete strain designations. Confirm them before describing the blend as selected for a women’s use case. General probiotic evidence cannot be applied to a different strain simply because the species name looks similar.
A buyer should be able to review the strain list, supplier documents, proposed CFU declaration and any population-specific evidence together. If that file is not available, keep the public language at formula and manufacturing level.
The formula lists 100 mg cranberry fruit extract standardized to at least 25% proanthocyanidins, or PACs. Keep the extract amount and standardization together. Do not turn the presence of cranberry into a treatment claim for urinary or vaginal conditions.
The supplier specification should state the botanical identity, fruit material, extract details, PAC assay and acceptance range. Different analytical methods are not automatically comparable, so any PAC statement used in sales material must follow the approved document.
FOS contributes 360 mg, while the probiotic blend, cranberry extract, zinc-enriched yeast material, vitamin D3 material and excipients also occupy the capsule. The stated zinc and D3 nutrient amounts are not necessarily the same as their raw-material input weights.
A fill trial should confirm shell size, blend flow and weight variation. If one capsule cannot hold the approved inputs with a practical manufacturing allowance, the buyer must choose between a larger shell, two-capsule serving or a revised formula.
The probiotic declaration needs a defined time point and finished-product stability support. Zinc and vitamin D3 need their own identity, assay, input calculation and blend-uniformity controls. One set of tests does not replace the other.
Because the current bottle provides 30 servings, package barrier, closure, induction seal, desiccant decision and storage wording should be reviewed for the final formula. Commercial copy should not claim a shelf-life guarantee before that package is qualified.
The commercial brief is different from a general synbiotic: the buyer is comparing the final women’s-use strain set, cranberry PAC specification, FOS load and supporting nutrient amounts.
Avoid urinary tract infection, bacterial vaginosis, yeast infection, discharge or vaginal-treatment claims. A disclaimer does not convert medical language into an acceptable product claim.
This product has no ready-stock designation. MOQ, sample route, lead time and packaging follow the destination market, strain set, CFU basis, capsule format and required label language.
Send the target market, pack count, shelf-life target and preferred women’s-wellness positioning with the enquiry. HEKONA can then identify which elements are supported, which require reformulation and which claims should be removed before artwork starts.
No. The formula may use cranberry as a defined component, but it must not be presented as treating or preventing a urinary condition.
The approved supplier specification and analytical method still need to be confirmed. Keep the 100 mg extract amount and its standardization together.
That requires a fill trial using the approved raw materials. Raw-material assays and carriers affect the actual input weight.
Send the destination market, preferred strains, CFU declaration, cranberry specification, capsule count and expected quantity. HEKONA will review formula fit, sampling, packaging, claim boundaries, MOQ and quotation.
This formula is intended for adult women looking for a daily probiotic supplement with cranberry, FOS, zinc and vitamin D3 in one capsule.
It may suit product lines targeting:
Final target-user wording, directions and claims should be reviewed for the intended sales market before label approval.
Whether you’re exploring new solutions, seeking technical support, or ready to start a project,our team is here to listen and collaborate.
